Lao version of ixazomib medication and purchasing guide

The Lao version of ixazomib is an important drug in the treatment of multiple myeloma, providing an affordable treatment option for many patients. To ensure patients can use this medication correctly and safely, detailed usage and purchasing guidelines are provided below.

1. Introduction to drugs

Ixazomib, a proteasome inhibitor, is a drug specifically used to treat multiple myeloma. It achieves the purpose of controlling the disease by inhibiting the proliferation of tumor cells.

2. Medication guidance

1. Recommended dose: The recommended starting dose for adult patients with multiple myeloma is 4 mg per time, administered orally. In a 28 day treatment cycle, medication is required on day 1, day 8 and day 15.

2. Best medication time: It is recommended to take it 1 hour before a meal or 2 hours after a meal to ensure the best absorption of the drug.

3. Taking tips: The capsule should be swallowed whole. It can be taken with water. Do not break it or chew it.

4. Handling of missed doses: If you miss a dose and the time before the next dose is less than 72 (3days) hours, there is no need to take a missed dose.

2. Precautions when using

1. Drug Interactions: Tell your doctor about all the drugs you currently use and any drugs you start or stop using.

2. Warning for special groups: Patients with childbearing potential need to take effective contraceptive measures during and within 90 days after treatment. Pregnant and nursing women should avoid use.

3. Response to side effects: If you experience discomfort symptoms such as nausea, vomiting, diarrhea or skin reactions, you should communicate with your doctor in time.

4. Drug storage recommendations

Please store medicine in a dry, dark place, away from moisture and heat. Also, make sure medications are stored out of the reach of children.

5. Specifications and price information

The common specifications of the Lao version of ixazomib are 4mg*3 tablets per box. The market price is about 900 yuan, providing patients with a more economical treatment option.

Overall, the Lao version of ixazomib provides an affordable and effective treatment option for patients with multiple myeloma. However, in order to ensure safety and effectiveness, patients should consult their doctor in detail before use and take the medication strictly in accordance with the doctor's instructions. If you have any questions or discomfort, you should contact your doctor immediately.